Please try another search
For the six months ended 31 October 2021, Sensyne Health PLC revenues decreased 56% to £1M. Net loss increased 53% to £21.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development expenses increase of 44% to £10.7M (expense), Other general and administration expense increase of 51% to £9M (expense).
Period Ending: | Oct 31, 2021 | Apr 30, 2021 | Oct 31, 2020 | Apr 30, 2020 |
---|---|---|---|---|
Total Revenue | 1.03 | 6.78 | 2.32 | 1.66 |
Gross Profit | 0.45 | 4.57 | 1.33 | 0.91 |
Operating Income | -21.02 | -14.39 | -13.59 | -12.61 |
Net Income | -21.12 | -13.71 | -13.81 | -11.95 |
Period Ending: | Oct 31, 2021 | Apr 30, 2021 | Oct 31, 2020 | Apr 30, 2020 |
---|---|---|---|---|
Total Assets | 42.12 | 61.99 | 38.12 | 53.93 |
Total Liabilities | 8.67 | 9.26 | 7.66 | 10.07 |
Total Equity | 33.45 | 52.73 | 30.47 | 43.86 |
Period Ending: | Oct 31, 2021 | Apr 30, 2021 | Oct 31, 2020 | Apr 30, 2020 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | -13.68 | -25.07 | -12.44 | -14.65 |
Cash From Investing Activities | -1.62 | -8.17 | -0.44 | -2.72 |
Cash From Financing Activities | -0.19 | 25.1 | -0.2 | -0.27 |
Net Change in Cash | -15.51 | -8.08 | -13.09 | -17.59 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review